< Back to previous page
Researcher
Dmitri Krysko
- Keywords:cell death, cancer biology, innate immunity, DC vaccine, cancer immunity, cancer therapy, glioma, immunogenic cell death
- Disciplines:Cancer therapy, Cell death, Vaccinology, Cancer biology
Affiliations
- Department of Human Structure and Repair (Department)
Member
From1 Oct 2018 → Today - Department of Basic Medical Sciences (Department)
Member
From1 Oct 2016 → 30 Sep 2018 - Department of Biomedical molecular biology (Department)
Member
From1 Jan 2006 → 30 Sep 2016 - Department of Human Anatomy, Embryology, Histology and Medical Physics (Department)
Member
From1 Jan 2002 → 31 Dec 2005
Infrastructure
1 - 1 of 1
- Atomic Force Microscope (Consortium partner)
Projects
1 - 10 of 16
- IIMMUNO—FER—GUARD: Immunotherapy-based Modality Using Dendritic cells Loaded with FERroptotic cancer Lysates - Guarding against Glioblastoma and MelanomaFrom20 Dec 2023 → TodayFunding: IOF - technology concept exploration
- Generation of tumor neoantigens with photodynamic therapy: a new strategy for anticancer vaccines to fight head and neck cancerFrom1 Dec 2023 → TodayFunding: Horizon Europe - Marie Skłodowska-Curie-actions
- Capacity strengthening for development of pore-forming proteins obtained from a Cuban natural source as Immunogenic Cell Death Inducers for cancer immunotherapyFrom1 Sep 2023 → TodayFunding: VLIR-UOS South Initiatives
- Novel photosensitizers to push the limits of photodynamic cancer therapyFrom14 Aug 2023 → TodayFunding: IOF - technology concept exploration
- Triple punch against melanoma: photodynamic therapy, immunogenic cell death and photothermal ablationFrom1 Jan 2023 → TodayFunding: BOF - projects
- Mechanobiology control of immunogenic cell death by bio-polymers for cancer therapyFrom1 Oct 2022 → TodayFunding: BOF - projects
- Unravelling the role of immunogenic cell death and endothelial cells in the tumour microenvironment and immunityFrom1 Oct 2022 → TodayFunding: BOF - doctoral mandates
- A patient derived xenograft (PDX) platform for in vivo evaluation of novel anticancer therapiesFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- White light laser-based confocal fluorescence lifetime imaging microscope for multi-parameter 3D live imagingFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Harnessing tumor acidosis and immunogenic ferroptosis for an innovative treatment of peritoneal carcinomatosis with PUFA-loaded nanovesiclesFrom1 Jan 2022 → TodayFunding: FWO EOS